CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
05 01 2020
Historique:
received: 14 11 2019
revised: 12 12 2019
accepted: 24 12 2019
entrez: 18 1 2020
pubmed: 18 1 2020
medline: 16 1 2021
Statut: epublish

Résumé

CD276 can discriminate between tumor derived and normal CECs (circulating endothelial cells). We evaluated whether CD276

Identifiants

pubmed: 31948091
pii: cells9010124
doi: 10.3390/cells9010124
pmc: PMC7016770
pii:
doi:

Substances chimiques

B7 Antigens 0
CD276 protein, human 0

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

S.S. and J.K. are co-patent holder of the CEC measurement method as described in the manuscript. E.G., L.B., T.B., B.Z., C.V., and H.V. declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Br J Cancer. 2014 Jul 8;111(1):149-56
pubmed: 24892449
JAMA. 2017 Jun 20;317(23):2392-2401
pubmed: 28632865
Lancet Oncol. 2014 Sep;15(10):1065-75
pubmed: 25088940
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Lancet. 2013 Jan 26;381(9863):303-12
pubmed: 23177514
Cancer Res. 2014 May 15;74(10):2731-41
pubmed: 24626092
Lancet Oncol. 2015 Oct;16(13):1306-15
pubmed: 26338525
Int J Colorectal Dis. 2015 Mar;30(3):315-21
pubmed: 25598043
Microvasc Res. 2010 May;79(3):224-8
pubmed: 20176038
Cancer Cell. 2007 Jun;11(6):539-54
pubmed: 17560335
J Cancer Res Clin Oncol. 2012 Jul;138(7):1187-96
pubmed: 22419441
J Clin Oncol. 2010 Nov 1;28(31):4697-705
pubmed: 20921465
Stem Cells Int. 2018 Nov 18;2018:9847015
pubmed: 30581475
Ann Oncol. 2010 Dec;21(12):2382-9
pubmed: 20497963
Ann Oncol. 2010 Dec;21(12):2447-8
pubmed: 21030382
Oncotarget. 2017 Jun 6;8(23):37491-37501
pubmed: 28415583
Clin Transl Oncol. 2017 Feb;19(2):227-235
pubmed: 27443414
Ann Oncol. 2012 Apr;23(4):919-27
pubmed: 21825101
Clin Colorectal Cancer. 2018 Mar;17(1):58-64
pubmed: 29157662
Cancer Chemother Pharmacol. 2011 Sep;68(3):763-8
pubmed: 21170650
J Thromb Haemost. 2012 May;10(5):931-9
pubmed: 22385979
Eur J Cancer. 2017 Oct;84:69-80
pubmed: 28787661

Auteurs

Elske C Gootjes (EC)

Department of Medical Oncology VUmc, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam 1081 HV, The Netherlands.

Jaco Kraan (J)

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam 3015 GD, The Netherlands.

Tineke E Buffart (TE)

Department of Medical Oncology VUmc, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam 1081 HV, The Netherlands.
Department of Gastrointestinal Oncology, Antoni van Leeuwenhoek, Amsterdam 1006 BE, The Netherlands.

Lotte Bakkerus (L)

Department of Medical Oncology VUmc, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam 1081 HV, The Netherlands.
Department of Gastrointestinal Oncology, Antoni van Leeuwenhoek, Amsterdam 1006 BE, The Netherlands.

Barbara M Zonderhuis (BM)

Department of Surgical Oncology VUmc, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam 1081 HV, The Netherlands.

Cornelis Verhoef (C)

Department of Surgical Oncology, Erasmus MC-Cancer Institute, Rotterdam 3015 GD, The Netherlands.

Henk M W Verheul (HMW)

Department of Medical Oncology VUmc, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam 1081 HV, The Netherlands.
Department of Medical Oncology, Radboud UMC, Nijmegen 6525 GA, The Netherlands.

And Stefan Sleijfer (AS)

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam 3015 GD, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH